Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-1.97 Mil
% of Total Estimate Gain
-27.30%

abrdn U.S. Small Cap Equity Fund's Amicus Therapeutics Inc Holding Summary

As of 2025-04-30, abrdn U.S. Small Cap Equity Fund held - shares of Amicus Therapeutics Inc(FOLD), totaling N/A. This investment constitutes 0% of their stock portfolio, and abrdn U.S. Small Cap Equity Fund now holds 0% of the outstanding Amicus Therapeutics Inc(FOLD) stock.

The initial trade took place in 2024Q2. And since then abrdn U.S. Small Cap Equity Fund has made 2 purchases of FOLD, at an average price of $11.99, for a total of 602,693.00 shares. In addition, there have been 3 sales at an average price of $8.72 for 602,693.00 shares. Based on historical transaction data and FOLD's current price of $6.05, abrdn U.S. Small Cap Equity Fund's estimated gain on his FOLD holdings is $-1.97 Mil, reflecting a -27.30% gain to date.

abrdn U.S. Small Cap Equity Fund FOLD ($6.05) Holding Chart

abrdn U.S. Small Cap Equity Fund FOLD ($6.05) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1